Furthermore, daily injection of the anti-CD44 antibody decreased blood glucose levels, weight gain, liver steatosis, and insulin resistance to the levels lower than anti-diabetes drugs metformin and pioglitazone (122). The gene discussed is CD44; the disease is diabetes mellitus.